Ascribe Bioscience Raises $2.5M Seed Round, Accelerates Trials Of Natural Crop Protection Product
Nov 11, 2021•over 3 years ago
Amount Raised
$2.5 Million
Round Type
seed
Description
Crop protection start-up Ascribe Bioscience has raised a $2.5M Seed Round co-led by The Yield Lab and Acre Venture Partners. Impact-oriented investors Trailhead Capital and Ponderosa Ventures also participated in the financing. The investment will enable Ascribe to accelerate commercial development of their lead product Phytalix: an environmentally-friendly, broad spectrum biopesticide based on a naturally-occurring small molecule from the soil microbiome.